Suppr超能文献

前入路联合肝下下腔静脉阻断术治疗大肝癌的右肝切除术:一项前瞻性随机对照试验

Anterior approach combined with infrahepatic inferior vena cava clamping right hepatic resection for large hepatocellular carcinoma: A prospective randomized controlled trial.

作者信息

Zhou Yan-Ming, Sui Cheng-Jun, Zhang Xiao-Feng, Li Bin, Yang Jia-Mei

机构信息

Department of Hepatobiliary and Pancreatovascular Surgery, First affiliated Hospital of Xiamen University Department of Special Treatment, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.

出版信息

Medicine (Baltimore). 2016 Jul;95(27):e4159. doi: 10.1097/MD.0000000000004159.

Abstract

BACKGROUND

The anterior approach (AA) technique has been reported to provide better operative and survival outcomes compared with the conventional approach for large right hepatocellular carcinoma (HCC) resection. However, this technique runs the risk of massive retrograde bleeding from the right hepatic vein or middle hepatic vein at the deeper plane of parenchymal transection. This study was designed to evaluate the efficacy of AA combined with infrahepatic inferior vena cava (IVC) clamping on the perioperative outcomes in patients undergoing right hepatic resection for large HCC in randomized clinical trial settings.

METHODS

A total of 101 patients undergoing right hepatic resection for large HCC were randomized to receive AA combined with infrahepatic IVC clamping (group A, n = 50), or AA alone (group B, n = 51).

RESULTS

The total blood loss (423 ± 154 vs 757 ± 338 mL; P = 0.001), blood loss during liver transection (272 ± 96 vs 563 ± 144 mL; P = 0.001), and intraoperative blood transfusion requirements (12.0% vs 29.4%; P = 0.031) were significantly less in group A patients compared with group B patients. There was no IVC clamping-associated morbidity in group A.

CONCLUSION

AA combined with infrahepatic IVC clamping for large right HCC resection is a safe, feasible, and effective technique in reducing intraoperative blood loss.

摘要

背景

据报道,对于大型右肝细胞癌(HCC)切除术,与传统手术方法相比,前入路(AA)技术能提供更好的手术效果和生存结局。然而,该技术在肝实质横断的更深层面存在右肝静脉或肝中静脉大量逆行出血的风险。本研究旨在通过随机临床试验评估AA联合肝下下腔静脉(IVC)阻断对大型HCC右肝切除术患者围手术期结局的疗效。

方法

总共101例接受大型HCC右肝切除术的患者被随机分组,分别接受AA联合肝下IVC阻断(A组,n = 50)或单纯AA(B组,n = 51)。

结果

与B组患者相比,A组患者的总失血量(423±154 vs 757±338 ml;P = 0.001)、肝横断期间的失血量(272±96 vs 563±144 ml;P = 0.001)和术中输血需求(12.0% vs 29.4%;P = 0.031)显著更少。A组无IVC阻断相关的并发症。

结论

AA联合肝下IVC阻断用于大型右HCC切除术是一种安全、可行且有效的减少术中失血的技术。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bed/5058865/04ed544c9381/medi-95-e4159-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验